Hemostatic system in Takotsubo patients at long-term follow-up: A hidden activation?

Int J Cardiol

12 September Sep 2023 9 months ago
  • Amadio P, Zarà M, Eligini S, Sandrini L, Werba JP, Cosentino N, Olivares P, Bonomi A, Trabattoni D, Barbieri SS

Takotsubo cardiomyopathy (TTS) has long been considered a benign condition, despite recurrent events and long-term adverse outcomes are often reported. Endothelial damage, blood hyperviscosity, and platelet activation described in acute phase persist in long-term follow-up; however, TTS pathophysiology is still not fully understood. Here, we explored the hemostatic system at a median of 3.1 years after TTS to uncover additional long-lasting changes in these patients.

Reference: Hemostatic system in Takotsubo patients at long-term follow-up: A hidden activation?
Amadio P, Porro B, Cavalca V, Zarà M, Eligini S, Sandrini L, Werba JP, Cosentino N, Olivares P, Galotta A, Bonomi A, Tremoli E, Trabattoni D, Barbieri SS. Int J Cardiol. 2023 Jul 30:131229.

Go to PubMed